1

Rigenera® Device

Patented medical device for mechanical disaggregation of autologous tissue biopsies.

2

AMT® Triad

Progenitor cells, Human Smart Exosomes and extracellular matrix extracted in one closed process.

3

Micrografting

Immediate injection of the solution into affected scalp zones with no delay and no manipulation.

Mechanism & Scientific Rationale

Androgenetic alopecia is characterized by progressive follicular miniaturization driven by DHT-mediated signaling at the dermal papilla. The AMT® approach aims to restore the follicular niche microenvironment by replenishing progenitor cells and paracrine mediators.

The mastoid area is biologically DHT-insensitive, providing a reliable source of healthy tissue. The mechanical disaggregation protocol preserves cell viability, exosome integrity, and extracellular matrix architecture.

Human Smart Exosomes within the AMT® triad carry tissue-specific bioactive cargo including growth factors, microRNAs, and signaling proteins that help modulate inflammation, stimulate follicular stem cell activity, and promote anagen re-entry.

Device & System Differentiators

Only Patented AMT® Platform

The only system with CE-marked autologous micrografting and no regulatory alternative.

No Biological Manipulation

Fully mechanical process with no enzymes, no culture, no expansion, and no cryopreservation required.

Tissue-Specific Exosomes

Autologous exosomes matched to the patient's own biology, not pooled donors or cell lines.

30-Minute Full Procedure

From biopsy to injection in a single session with no laboratory downtime.

70 Billion Exosomes Quantified

Scientifically validated exosome yield per treatment, first in the market to quantify this.

Protocol Overview

Complete in-office procedure with no lab required and no pre-processing downtime.

1

Patient Assessment

Evaluate diagnosis, scalp condition, pattern of loss, and clinical suitability before planning the procedure.
2

Biopsy Collection

Small autologous tissue samples are collected from the mastoid area using the prescribed protocol.
3

Mechanical
Disaggregation

The Rigenera device processes the tissue mechanically to preserve cells, exosomes, and extracellular matrix.
4

Scalp Preparation

Target areas are prepared for precise placement of the autologous regenerative solution.
5

AMT®
Injection

The prepared micrograft solution is immediately injected into affected scalp zones in the same session.
6

Post-procedure

No dressing required. The patient is discharged immediately with advice on expected mild scalp sensitivity for 24-48 hours.
Candidate Selection

Who Is a
Good Candidate?

  • Androgenetic alopecia (AGA), male or female pattern.

  • Preference for an autologous, minimally invasive approach.

  • Patients seeking adjunctive therapy to pharmacological treatment.

  • Post-transplant scalp maintenance and follicular support.

  • Early to moderate thinning with preserved follicular units.

  • Patients suitable for periodic in-office regenerative maintenance.

Contraindications

When Not
to Treat

  • Active scalp infections including bacterial, fungal, or viral conditions.

  • Autoimmune alopecias such as alopecia areata, totalis, or universalis.

  • Scarring alopecias including lichen planopilaris and frontal fibrosing alopecia.

  • Active systemic inflammatory disease or uncontrolled comorbidities.

  • Pregnancy or breastfeeding.

  • Diffuse unpatterned alopecia (DUPA) as a relative contraindication.

Frequently Asked Questions

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s